BioNote, Inc.

₩4,620As of Sun 8 Nov 2026, 12:00 UTC
KRX:377740Healthcare
Country South Korea
PE (Fwd) •••
TSR 4Y CAGR (11.93%)
Div yield 4.93%
ROE (7.79%)
Medical Devices
Beta (5Y) 0.58
PE TTM —
TSR TTM (12.51%)
Mkt cap ₩466.2B
ROIC 1.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,397
(4.83%)
73.57%
Hold 5|0|7|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
68.38
75.22
83.19
89.11
(12.99%)
(0.19%)
15.53%
28.15%
Revenue₩B
61.48
64.75
64.91
67.37
6.38%
6.60%
8.72%
10.72%
Peers (US$343.7M)
Cap (US$)
PE
413.8M
11.79x
409.9M
13.32x
276.0M
7.401x
Capital
TTM
5Y
10Y
Leveragex
0.368
0.038
0.034
EBIT/Intx
0.195
0.224
0.172
Own earn%
(82.63)
(10.66)
(16.82)
Sh yield%
27.65
38.32
37.31
Owners
Insiders/Inst%
6.87
40.53
Short interest%
3.07
SBC / revenue%
4.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–6
$1 testx
0.0
Incr. ROIC%
27